Mostafa Ronaghi (Persian: مصطفی رونقی; born 1968) is an Iranian molecular biologist, specializing in DNA sequencing methodology. He earned his Ph.D. from the Royal Institute of Technology in Sweden in 1998. As of 2008, he is the Chief Technology Officer and Senior Vice President at Illumina. Prior to this position, he was a principal investigator and Senior Research Associate at the at Stanford University, focusing on developing analytical techniques for molecular diagnostics.
| Attributes | Values |
|---|
| rdf:type
| |
| rdfs:label
| - Mostafa Ronaghi (fr)
- Mostafa Ronaghi (en)
|
| rdfs:comment
| - Mostafa Ronaghi (Persian: مصطفی رونقی; born 1968) is an Iranian molecular biologist, specializing in DNA sequencing methodology. He earned his Ph.D. from the Royal Institute of Technology in Sweden in 1998. As of 2008, he is the Chief Technology Officer and Senior Vice President at Illumina. Prior to this position, he was a principal investigator and Senior Research Associate at the at Stanford University, focusing on developing analytical techniques for molecular diagnostics. (en)
- Mostafa Ronaghi (en persan : مصطفی رونقی, né en 1968) est un biologiste moléculaire iranien, spécialisé dans la méthodologie de séquençage de l'ADN. Il a obtenu son doctorat de l'Institut royal de technologie de Suède en 1998. En 2000, il est directeur de la technologie et vice-président d'Illumina. Avant d'occuper ce poste, il était chercheur principal et associé de recherche principal au Stanford Genome Technology Center de l'Université de Stanford, où il se concentrait sur le développement de techniques analytiques pour les diagnostics moléculaires. (fr)
|
| foaf:depiction
| |
| dct:subject
| |
| Wikipage page ID
| |
| Wikipage revision ID
| |
| Link from a Wikipage to another Wikipage
| |
| Link from a Wikipage to an external page
| |
| sameAs
| |
| dbp:wikiPageUsesTemplate
| |
| thumbnail
| |
| has abstract
| - Mostafa Ronaghi (en persan : مصطفی رونقی, né en 1968) est un biologiste moléculaire iranien, spécialisé dans la méthodologie de séquençage de l'ADN. Il a obtenu son doctorat de l'Institut royal de technologie de Suède en 1998. En 2000, il est directeur de la technologie et vice-président d'Illumina. Avant d'occuper ce poste, il était chercheur principal et associé de recherche principal au Stanford Genome Technology Center de l'Université de Stanford, où il se concentrait sur le développement de techniques analytiques pour les diagnostics moléculaires. Il est chercheur principal pour plusieurs subventions, notamment des subventions du National Human Genome Research Institute (NHGRI), qui fait partie du National Institutes of Health pour le développement du pyroséquençage basé sur des puces. En 1998, il a décrit avec Pål Nyren et Mathias Uhlen une variante basée sur des solutions de la technologie de pyroséquençage et a cofondé Pyrosequencing AB (rebaptisé Biotage en 2003). Il a co-inventé le test Molecular Inversion Probe et a cofondé ParAllele BioScience pour développer cette technologie multiplexée pour les tests génétiques. ParAllele a été acquis par Affymetrix en mai 2005. En 2005, il a cofondé NextBio, un moteur de recherche de données sur les sciences de la vie acquis par Illumina en 2013 . Il siège également au conseil d'administration d'IntegenX et d'Aurora Biofuels. En 2008, Ronaghi et Helmy Eltoukhy ont co-fondé Avantome, une société de séquençage d'ADN qui a été acquise par Illumina en juillet 2008 . (fr)
- Mostafa Ronaghi (Persian: مصطفی رونقی; born 1968) is an Iranian molecular biologist, specializing in DNA sequencing methodology. He earned his Ph.D. from the Royal Institute of Technology in Sweden in 1998. As of 2008, he is the Chief Technology Officer and Senior Vice President at Illumina. Prior to this position, he was a principal investigator and Senior Research Associate at the at Stanford University, focusing on developing analytical techniques for molecular diagnostics. He is principal investigator for several grants including grants from the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health for the development of array-based Pyrosequencing. In 1998, he described together with Pål Nyren and Mathias Uhlen a solution-based variant of the pyrosequencing technology and co-founded Pyrosequencing AB (renamed to Biotage in 2003). He co-invented Molecular Inversion Probe assay and co-founded ParAllele BioScience to develop this multiplexed technology for genetic testing. ParAllele was acquired by Affymetrix in May 2005.In 2005, he co-founded , a search engine for life science data that was acquired by Illumina in 2013. He also serves on the board of directors of IntegenX and Aurora Biofuels. In 2008, Ronaghi and Helmy Eltoukhy co-founded Avantome, a DNA sequencing company that was acquired by Illumina in July 2008. (en)
|
| gold:hypernym
| |
| prov:wasDerivedFrom
| |
| page length (characters) of wiki page
| |
| foaf:isPrimaryTopicOf
| |
| is Link from a Wikipage to another Wikipage
of | |
| is Wikipage redirect
of | |
| is founder
of | |
| is founded by
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)
